Supplemental Table 1 - Application Site Adverse Events of Topical Nonsteroidal Immunomodulators: A Post-Marketing Analysis of The FDA Adverse Event Reporting System
Published: 18 June 2026| Version 1 | DOI: 10.17632/7njfpzfjhh.1
Contributor:
Camila MarquezDescription
Supplemental table for Application Site Adverse Events of Topical Nonsteroidal Immunomodulators: A Post-Marketing Analysis of The FDA Adverse Event Reporting System.
Files
Institutions
- University of WashingtonWashington, Seattle
Categories
Dermatology, Pharmacovigilance